From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Keyword results: trolled


VINDICATED YET AGAIN: Versarien bailout placing fails to hit targets, death postponed by only 2 months (at most!)

This is so simple that even the most moronic or Bulletin Board morons or spiv, Scouse, penny share grifter, share promoters should get it: companies do not set out to raise £531,624 (gross) in a deeply discounted placing. They go for a round number. A company running on vapours raising a non round number and way below what it had the authorities to raise is a sign that only forward sellers and flippers were interested. I refer to Versarien (VRS). Its latest placing is a disaster.
Subscribe to ShareProphets to access Premium Content

100% Vindication for @TomWinnifrith: Shield Therapeutics admits to failed $30m placing, gets bailout loan but will still be bust by Christmas

Oh dear, oh dear. This is truly awful, and explains why results normally released in late April, came out today - deadline day. Shield Therapeutics (STX) is in a mess, as I warned so often. Ouzo for me. Cabbage water for those who ignored my explicit warnings and instead, hurled abuse at me.

Subscribe to ShareProphets to access Premium Content
Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Complete Coverage

Recent Comments

Time left: 11:27:16